SuZhou Stainwei Biotech Inc.   Report issue

For profit Phase 1
Founded: Suzhou China (2005)

Organization Overview

First Clinical Trial
2018
NCT03503604
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

SuZhou Stainwei Biotech Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 8